Comparative Pharmacology
Head-to-head clinical analysis: ACLOVATE versus FLUONID.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACLOVATE versus FLUONID.
ACLOVATE vs FLUONID
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Aclovate (alclometasone dipropionate) is a synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. Its mechanism involves binding to glucocorticoid receptors, modulating gene expression to inhibit phospholipase A2, reducing arachidonic acid release, and decreasing prostaglandin and leukotriene synthesis.
Fluocinolone acetonide is a corticosteroid that binds to the glucocorticoid receptor, leading to inhibition of phospholipase A2, reduction of prostaglandin and leukotriene synthesis, and suppression of inflammatory mediators.
Apply a thin film to affected skin areas twice daily. Not for ophthalmic, oral, or intravaginal use.
0.05% cream or ointment applied topically to affected area once daily. Not to exceed 30 g per week.
None Documented
None Documented
Terminal elimination half-life: approximately 6-8 hours after topical application; systemic absorption is minimal under normal use.
3.5 hours; prolonged to 18–24 hours in severe hepatic impairment.
Renal (primarily as metabolites, <5% unchanged), biliary/fecal (minor).
Renal 70% as unchanged drug, biliary/fecal 30% as metabolites.
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid